<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Musculoskeletal manifestations of amyloidosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Musculoskeletal manifestations of amyloidosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Musculoskeletal manifestations of amyloidosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter D Gorevic, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Helen J Lachmann, MA, MB, BChir, MD, FRCP, FRCPath, FMedSci</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Siobhan M Case, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 14, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Amyloidosis refers to the extracellular tissue deposition of fibrils that are composed of low-molecular-weight subunits (5 to 25 kD) derived from a variety of serum proteins. These fibrils adopt a beta-pleated-sheet-rich configuration that is reflected in characteristic histologic changes. Amyloid deposits can occur in a variety of organs, with involvement of the heart, kidney, gastrointestinal tract, and nervous system often responsible for morbidity and mortality.</p><p>The identity of the fibril subunit protein varies with the type of amyloidosis. It is a monoclonal immunoglobulin light chain or light chain fragment in AL amyloidosis (which may be a complication of plasma cell dyscrasias), a fragment of serum amyloid A (SAA) protein in AA amyloidosis (which is a complication of chronic inflammatory disorders), and beta-2 microglobulin in dialysis-related amyloidosis. (See  <a class="medical medical_review" href="/z/d/html/6665.html" rel="external">"Monoclonal immunoglobulin deposition disease"</a> and  <a class="medical medical_review" href="/z/d/html/5619.html" rel="external">"Pathogenesis of AA amyloidosis"</a> and  <a class="medical medical_review" href="/z/d/html/1983.html" rel="external">"Dialysis-related amyloidosis"</a>.)</p><p>A variety of amyloid types are associated with musculoskeletal disease, including AL, transthyretin (ATTR), and beta-2 microglobulin (A beta-2m) amyloidosis. These can be distinguished immunohistologically and biochemically and require different treatment strategies [<a href="#rid1">1</a>]. Musculoskeletal manifestations of amyloid deposition may be subtle, subclinical, and only apparent when a tissue biopsy is carried out [<a href="#rid2">2</a>]. Rarely, patients present with a clinical picture that simulates a known rheumatic disease. In addition, musculoskeletal disorders may be the cause rather than the result of AA amyloidosis.</p><p>The musculoskeletal manifestations of the various forms of amyloidosis are presented here. An overview of amyloidosis and the rheumatic and other disorders that can be complicated by AA amyloidosis are described separately. (See  <a class="medical medical_review" href="/z/d/html/5589.html" rel="external">"Overview of amyloidosis"</a> and  <a class="medical medical_review" href="/z/d/html/5602.html" rel="external">"Causes and diagnosis of AA amyloidosis and relation to rheumatic diseases"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">AL AMYLOIDOSIS</span><span class="headingEndMark"> — </span>Musculoskeletal manifestations of AL amyloid include muscle weakness (myopathy) and enlargement due to amyloid infiltration (pseudohypertrophy), disorders of the joints (arthropathy), and lesions of bone (osteopathy). Other manifestations of AL amyloidosis are described separately. (See  <a class="medical medical_review" href="/z/d/html/6668.html" rel="external">"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Muscle involvement in AL amyloid</span><span class="headingEndMark"> — </span>Amyloid infiltration of muscles may cause:</p><p class="bulletIndent1"><span class="glyph">●</span>Visible enlargement (ie, pseudohypertrophy) [<a href="#rid3">3-6</a>].</p><p></p><p class="bulletIndent1">A large tongue (ie, macroglossia) or lateral scalloping of the tongue from impingement on the teeth is characteristic of AL amyloid and may be the presenting feature of the disease [<a href="#rid7">7,8</a>].</p><p></p><p class="bulletIndent1">Muscle infiltration is generally associated with widespread or systemic involvement. In a retrospective study conducted at a single tertiary center, 12 patients with biopsy-proven amyloid myopathy were identified over a 35-year period [<a href="#rid9">9</a>]. Muscular pseudohypertrophy was present in one-quarter of these patients. Muscle involvement accompanied widespread organ involvement in most patients and was associated with a median survival of 12 months. A significant number of these patients had electrophysiologic abnormalities, reflecting direct involvement or associated neuropathy [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Myopathy may occasionally be the initial presenting feature of AL amyloid; the diagnosis may be suggested by unusual findings on magnetic resonance imaging (MRI) or positron emission tomography (PET)/computed tomography (CT) scanning and confirmed by biopsy [<a href="#rid11">11-13</a>]. A spectrum of light chain deposition and pathologies may be seen [<a href="#rid14">14</a>]. Symptoms include proximal muscle weakness or dyspnea [<a href="#rid15">15</a>]; rarely, the presentation can simulate polymyositis [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">A retrospective review of 51 patients seen in a tertiary referral setting with AL amyloidosis and biopsy-confirmed amyloid myopathy reported presenting symptoms of muscle weakness (proximal greater than distal) in 45 percent, myalgia (33 percent), macroglossia (33 percent), jaw claudication (25 percent), and hoarseness (18 percent). In over one-third of patients with muscle biopsies prior to referral, the initial biopsy had been misinterpreted or not fully evaluated, with further testing of the tissue or reevaluation needed to establish amyloid as the cause of myopathy; 88 percent of those tested showing myopathic changes on electromyography; 50 percent had coexistent peripheral neuropathy. Elevation of cardiac troponin T in the absence of cardiac involvement was found to be a useful indication of muscle involvement in AL amyloidosis [<a href="#rid17">17</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Arthropathy due to AL amyloid</span><span class="headingEndMark"> — </span>Amyloid deposits in AL amyloidosis can involve the synovium, leading to rheumatic symptoms. As an example, amyloid arthropathy is a rare complication of Waldenström macroglobulinemia [<a href="#rid18">18</a>], and an erosive arthritis has been described in patients with monoclonal gammopathy of uncertain significance [<a href="#rid19">19</a>]. Amyloid arthropathy may occur in 0.1 to 6 percent of patients with multiple myeloma, with an onset either coincident with or subsequent to the diagnosis of myeloma [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/6657.html" rel="external">"Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenström macroglobulinemia"</a> and  <a class="medical medical_review" href="/z/d/html/6652.html" rel="external">"Diagnosis of monoclonal gammopathy of undetermined significance"</a>.)</p><p>More typically, the arthropathy in AL amyloid is low grade, subacute, progressive, and symmetric, with a predilection for the shoulders, knees, wrists, and metacarpophalangeal and proximal interphalangeal joints and, to a lesser degree, for the elbows and hips. The joints are mildly tender or nontender, and there is usually little morning stiffness.</p><p>These characteristics help distinguish this disorder from rheumatoid arthritis [<a href="#rid21">21,22</a>]. However, a potentially misleading finding is the presence of whitish subcutaneous nodules in about 60 percent of cases; these nodules are typically in and around the joint and are on the extensor surfaces of the forearms and elsewhere. A biopsy demonstrating Congo red birefringent material will clearly distinguish these lesions from rheumatoid nodules [<a href="#rid23">23</a>]. Arthropathy as well as tendinopathy may improve with appropriate chemotherapy, documented by regression of lesions assessed by ultrasound or MRI [<a href="#rid24">24</a>].</p><p>Radiographic features include juxtaarticular cyst formation, widening of the joint space early in the disease, and soft tissue infiltration in a periarticular distribution that may be demonstrable by MR and/or ultrasound imaging [<a href="#rid20">20,25</a>] or, in some instances, by 18F-FDG PET/CT [<a href="#rid26">26</a>].</p><p>Results from two large series showed the following:</p><p class="bulletIndent1"><span class="glyph">●</span>In one series, soft tissue, bone, and joint manifestations were identified for 42.9 percent of 191 patients with AL amyloidosis and were found to be the dominant organ system involvement for 9.4 percent [<a href="#rid27">27</a>]. The most common findings were macroglossia (23 percent), carpal tunnel syndrome (CTS; 13.1 percent), amyloid arthropathy (3.7 percent), and pseudohypertrophy of skeletal muscles (1.6 percent). Soft tissue and bone involvement were more common among patients with multiple organ involvement and were 3.9- to 4.3-fold higher among patients found to have underlying multiple myeloma and twofold higher among men than among women.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A systematic review of 101 published cases of amyloid arthropathy associated with multiple myeloma reported a male-to-female ratio of 1:1, with seronegative arthritis preceding the diagnosis of multiple myeloma in 62 percent, and typical amyloidosis-associated extraarticular manifestations, including either CTS, macroglossia, or shoulder pad and soft tissue swelling/masses, were present in 61 percent. Although most cases were symmetric and polyarticular, 17 percent were oligoarticular, and 3 of 101 were monoarticular [<a href="#rid28">28</a>]. Joint fluid is usually bland compared with typical findings in rheumatoid arthritis, and synovial histopathology is distinguished by the absence of CD20+ and CD38+ cells infiltration or angiogenesis; amyloid phagocytosis by synovial macrophages is characteristic [<a href="#rid29">29</a>].</p><p></p><p>A number of other rheumatic manifestations may also be observed in AL amyloid:</p><p class="bulletIndent1"><span class="glyph">●</span>Soft tissue swelling may be prominent in up to 75 percent of cases due to a nodular hypertrophied synovium directly infiltrated by amyloid. Swelling may be particularly prominent around the glenohumeral joint, resulting in a characteristic "shoulder pad" sign [<a href="#rid30">30</a>]. Direct extraction of amyloid from tissue taken at the time of synovectomy in one case yielded three subunit proteins, all derived from the same VkI light chain as determined by their amino terminal sequence [<a href="#rid31">31</a>]. In another study, a VkIII protein was extracted from the synovium of a patient with AL amyloid manifesting as a shoulder pad sign [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the hand is involved, there may be nodularity and thickening of the palmar fascia, with 50 percent of patients developing flexion contractures and weakness. Erosions and joint space narrowing are prominently absent, and there may even be widening of the joint space radiographically. Aspirated joint fluid is usually noninflammatory, with predominantly mononuclear cells; the fluid may appear cloudy due to the presence of synovial fragments, which can be shown to contain amyloid by Congo red staining of the spun sediment [<a href="#rid20">20,33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hand involvement is commonly associated with CTS, which is typically bilateral and symmetric. Nodular masses accumulate in the carpal tunnel and are often grossly apparent at the time of surgery [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rarely, Charcot-like arthropathy may result from severe amyloid neuropathy [<a href="#rid35">35</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Osteopathy due to AL amyloidosis</span><span class="headingEndMark"> — </span>Localized solitary or multiple osteolytic lesions of bone may be filled with amyloid. These lesions may lead to pathologic fractures and bone pain, possibly suggesting an underlying malignancy [<a href="#rid36">36-38</a>], and may cause significant neurologic deficits in multiple myeloma [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H6"><span class="h2">AL amyloid simulating other rheumatic diseases</span><span class="headingEndMark"> — </span>AL amyloid should be considered in the differential diagnosis of jaw claudication along with giant cell (temporal) arteritis/polymyalgia rheumatica [<a href="#rid40">40,41</a>]. Jaw claudication is due to predominantly vascular amyloid that compromises the lumina of the facial branches of the external carotid artery [<a href="#rid42">42,43</a>]. The presence of a monoclonal gammopathy and lack of response to glucocorticoids suggest the diagnosis of AL amyloid [<a href="#rid41">41,44</a>]. (See  <a class="medical medical_review" href="/z/d/html/8225.html" rel="external">"Clinical manifestations of giant cell arteritis"</a>.)</p><p>Sicca syndrome can occur due to amyloid deposits leading to enlargement and compromised function of both parotid and lacrimal glands [<a href="#rid45">45,46</a>]. This entity may be more prevalent than previously recognized, as evidenced by the high diagnostic yield of biopsy of the minor salivary lip glands in these patients [<a href="#rid47">47,48</a>].</p><p>Nodular amyloid in the lung and skin can complicate Sjögren's disease. In some cases, however, the amyloid deposits are due to either a localized form of amyloidosis or a systemic light chain deposition due to concomitant multiple myeloma [<a href="#rid49">49-52</a>].</p><p>Cutaneous disease mimicking scleroderma may be the presenting feature of AL amyloid, usually associated with multiple myeloma [<a href="#rid53">53,54</a>].</p><p class="headingAnchor" id="H7"><span class="h1">DIALYSIS-RELATED AMYLOIDOSIS</span><span class="headingEndMark"> — </span>Musculoskeletal manifestations of dialysis-related amyloidosis, including carpal tunnel syndrome (CTS), periarthritis of the shoulder, effusive arthropathy, and erosive bone lesions, are presented in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1983.html" rel="external">"Dialysis-related amyloidosis"</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">OSTEOARTICULAR AMYLOIDOSIS</span><span class="headingEndMark"> — </span>To a large degree, osteoarticular amyloid is an incidental histopathologic finding, and it remains unclear whether its presence identifies patients with earlier-onset or more rapidly developing forms of age-related musculoskeletal disease. Microdeposits of amyloid have been found as incidental findings in the fibrous capsules, cartilage, and synovial membranes of hip joints sampled by closed synovial membrane biopsy or at surgery for osteoarthritis [<a href="#rid55">55</a>], in fragments of menisci accessed by arthroscopy [<a href="#rid56">56</a>], in the menisci, articular cartilage, and synovial membrane of the knee in patients undergoing total joint arthroplasty for osteoarthritis [<a href="#rid57">57</a>], and in biopsies of the supraspinatus tendons of patients undergoing rotator cuff surgery [<a href="#rid58">58</a>]. These deposits can also be commonly demonstrated at postmortem examination in the hip, in the fibrocartilaginous discs of sternoclavicular joints, and in the intervertebral discs, both in the annulus fibrosus between collagen bundles and in the nucleus pulposus [<a href="#rid59">59-61</a>]. The incidence of osteoarticular amyloid varies with the age of the individual [<a href="#rid59">59</a>].</p><p>At least some forms of osteoarticular amyloid appear to be localized at the site of origin, as suggested by the lack of proximity to blood vessels or evidence of congophilic angiopathy and by the location deep in relatively acellular matrix material. A direct relationship to aging appears to be more important than to osteoarthritis [<a href="#rid62">62</a>], and an association with calcium pyrophosphate dihydrate crystals has been noted by several investigators [<a href="#rid61">61-63</a>]. Similar pathologic changes have been found in articular cartilage, joint capsules, and annulus fibrosus of the intervertebral discs of certain AKR-derived senescence-accelerated mouse (SAM/P) lines that have served as models for spontaneous age-related amyloidosis; in these animals, both apoprotein AII and serum amyloid A (SAA) were found in articular structures, with the latter correlating with systemic signs of inflammation at autopsy [<a href="#rid64">64</a>].</p><p>Amyloid extracted from the menisci of patients undergoing knee replacement surgery contains aminoterminal fragments of apolipoprotein AI (Apo A-I) [<a href="#rid65">65</a>]. Immunohistochemistry, immunostaining, and in situ hybridization suggested that the Apo A-I in the amyloid deposits originated from adjacent chondrocytes.</p><p>By contrast, a survey of osteoarthritic hips taken at the time of surgery implicated transthyretin (TTR) as the main immunoreactivity detected, assumed to be wild-type based upon the lack of mutations of affected individuals who underwent genetic testing [<a href="#rid66">66,67</a>]. While the contribution of Apo A-I to osteoarticular amyloid decreased, that of TTR increased with age [<a href="#rid57">57</a>]. TTR immunohistochemistry and western blot analysis were correlated with Congo red staining of human cartilage samples collected at the time of joint replacement, and osteoarthritis-related genes were found to be upregulated in chondrocytes exposed to amyloidogenic TTR [<a href="#rid68">68</a>]. Cartilage and synovitis histologic scores were increased in transgenic mice overexpressing wild-type human TTR following medial meniscus destabilization, a model for osteoarthritis, and also increased by intraarticular injection of aggregated TTR in wild-type mice of the same strain [<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H1854229527"><span class="h1">TRANSTHYRETIN AND JUVENILE IDIOPATHIC ARTHRITIS</span><span class="headingEndMark"> — </span>In juvenile idiopathic arthritis, misfolding, aggregation, and oxidation of TTR was shown in synovial fluid, which was demonstrated to be a target for both B- and T-cell immune responses [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H9"><span class="h1">FAMILIAL AMYLOIDOTIC POLYNEUROPATHY (FAP)</span><span class="headingEndMark"> — </span>Arthropathy and muscle involvement may occur in patients with familial amyloidotic polyneuropathy (FAP).</p><p class="headingAnchor" id="H10"><span class="h2">Arthropathy</span><span class="headingEndMark"> — </span>Loss of sensation to a joint may result in a chronic, progressive, and destructive arthropathy. The prototype of this disorder was described by Charcot in relation to tabes dorsalis. Similar changes are seen with other neurologic disorders, such as syringomyelia and diabetic neuropathy. Erosive and Charcot-like arthropathy, in some instances associated with intraarticular amyloid deposition due to variant transthyretin (TTR) subunit proteins, has been described in specific kindreds affected by FAP [<a href="#rid71">71-73</a>].</p><p>Clinical and imaging features of the neuropathic arthropathy in patients with FAP are similar to those seen in diabetic polyneuropathy. (See  <a class="medical medical_review" href="/z/d/html/5608.html" rel="external">"Diabetic neuroarthropathy"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Muscle involvement</span><span class="headingEndMark"> — </span>Amyloid angiopathy may contribute to muscle weakness and atrophy that may be a prominent feature in some kindreds affected by FAP [<a href="#rid74">74</a>]. Amyloid may be a cause of myopathy and neuropathy affecting individuals with the Ile122 variant of transthyretin cardiomyopathy common among African Americans [<a href="#rid75">75</a>], as well as patients with wild-type TTR cardiac disease and neuropathy [<a href="#rid76">76</a>]. Myopathy may be the initial manifestation of disease or develop de novo after liver transplantation [<a href="#rid77">77</a>].</p><p class="headingAnchor" id="H2713534231"><span class="h2">Carpal tunnel syndrome</span><span class="headingEndMark"> — </span>The presence of TTR in flexor retinaculum taken at the time of carpal tunnel release (CTR) is well recognized to occur in idiopathic and apparently localized carpal tunnel syndrome (CTS) [<a href="#rid78">78</a>], but also as a harbinger or concomitant of several TTR mutations responsible for polyneuropathy or cardiomyopathy [<a href="#rid79">79-82</a>]. CTS may be the presenting symptom of wild-type TTR amyloid [<a href="#rid83">83</a>], with approximately 98 percent showing median nerve entrapment electrophysiologically and approximately 48 percent giving a history of CTR up to 12 years preceding the diagnosis of cardiac amyloidosis [<a href="#rid84">84</a>].</p><p class="headingAnchor" id="H12764777"><span class="h2">Nerve involvement</span><span class="headingEndMark"> — </span>Laser microdissection and mass spectroscopic-based proteomics of nerve biopsies have been shown to be an effective way of classifying and characterizing AL amyloid and FAP-associated proteins causing polyneuropathy [<a href="#rid85">85</a>]. Patients with ATTR cardiac amyloidosis have an increased incidence of preceding carpal tunnel, polyneuropathy, myopathy, osteoarthritis requiring joint replacement, and spinal stenosis [<a href="#rid86">86-88</a>].</p><p class="headingAnchor" id="H12"><span class="h1">INCLUSION BODY MYOSITIS</span><span class="headingEndMark"> — </span>Some experts have suggested that amyloid deposition may have an important role in inclusion body myositis (IBM), but the importance of amyloid in the etiopathogenesis of this disorder remains uncertain [<a href="#rid89">89</a>]. The clinical manifestations, diagnosis, and pathogenesis of IBM are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5163.html" rel="external">"Clinical manifestations and diagnosis of inclusion body myositis"</a>.)</p><p class="headingAnchor" id="H1933232057"><span class="h1">OTHER FORMS OF ISOLATED AMYLOID MYOPATHY</span><span class="headingEndMark"> — </span>Although AL, mutant, and wild-type transthyretin amyloidosis (ATTR) accounted for 38 out of 52 cases of pathologically confirmed amyloid myopathy in one review, approximately 27 percent were found to be due to other disorders [<a href="#rid90">90</a>], notably including specific forms of muscular dystrophy.</p><p class="headingAnchor" id="H2084026190"><span class="h1">DYSFERLIN-DEFICIENT MUSCULAR DYSTROPHY</span><span class="headingEndMark"> — </span>Mutations in dysferlin can be associated with recessively inherited limb girdle muscular dystrophy type 2B. There have been reports of dysferlin-derived amyloid in skeletal muscle biopsies associated with mutations in the N-terminal of the protein [<a href="#rid91">91,92</a>].</p><p class="headingAnchor" id="H1619796435"><span class="h1">ANOCTAMIN 5 MUSCULAR DYSTROPHY</span><span class="headingEndMark"> — </span>Recessive mutations in anoctamin 5 (ANO5) cause limb-girdle muscular dystrophy 2L and distal muscular dystrophy, which are similar to dysferlin-deficient muscular dystrophy, including case reports of skeletal muscle amyloid deposits. This type of muscular dystrophy has a variable phenotype, including cardiac dysfunction, myalgias, and even rhabdomyolysis with significantly elevated creatinine kinase (CK) levels (unlike most other forms of amyloid myopathy), but whether there is any contribution from amyloid deposition is unknown [<a href="#rid90">90,93,94</a>].</p><p class="headingAnchor" id="H1296950"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>AL amyloid can cause muscle weakness and, in a minority of patients, can result in enlargement of muscles, termed pseudohypertrophy, due to amyloid infiltration. (See <a class="local">'Muscle involvement in AL amyloid'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Amyloid deposits in AL amyloidosis can involve the synovium, leading typically to a low-grade, subacute, progressive, and symmetric arthropathy, with a predilection for the shoulders, knees, wrists, and metacarpophalangeal and proximal interphalangeal joints. The joints are mildly tender or nontender, and there is usually little morning stiffness. Nodules containing amyloid may develop. Amyloid arthropathy is an infrequent complication of multiple myeloma or other paraproteinemia. (See <a class="local">'Arthropathy due to AL amyloid'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Localized solitary tumoral or multiple osteolytic lesions of bone containing amyloid may develop in patients with AL amyloidosis. These lesions may lead to pathologic fractures and bone pain. Other rheumatic manifestations of AL amyloid include jaw claudication that mimics giant cell (temporal) arteritis due to vascular amyloid and sicca syndrome due to exocrine gland involvement. (See <a class="local">'Osteopathy due to AL amyloidosis'</a> above and <a class="local">'AL amyloid simulating other rheumatic diseases'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Musculoskeletal manifestations of dialysis-related amyloidosis include carpal tunnel syndrome (CTS), periarthritis of the shoulder, effusive arthropathy, and erosive bone lesions. (See  <a class="medical medical_review" href="/z/d/html/1983.html" rel="external">"Dialysis-related amyloidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Microdeposits of amyloid have been found as incidental findings in the fibrous tissues, cartilage, menisci, and synovial membranes of various joints and in the annulus fibrosus and nucleus pulposus in the spine. The incidence of osteoarticular amyloid increases with advancing age. Some of these deposits contain apolipoprotein AI (Apo A-I), and some have been reported to have transthyretin (TTR) immunoreactivity. (See <a class="local">'Osteoarticular amyloidosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TTR may facilitate the upregulation of genes associated with cartilage degeneration and inflammation in osteoarthritis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Arthropathy and muscle involvement may occur in patients with familial amyloidotic polyneuropathy. (See <a class="local">'Arthropathy'</a> above and <a class="local">'Muscle involvement'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The development of CTS in patients on chronic hemodialysis was the first observation that led to recognition and characterization of dialysis amyloidosis due to beta-2 microglobulin. CTS may complicate AL and transthyretin amyloid (ATTR) and is a frequent presentation for both variant and wild-type ATTR cardiac amyloidosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Isolated amyloid myopathy with elevated creatinine kinase (CK) levels may occur in the dysferlin-deficient and anoctamin 5 (ANO5) forms of muscular dystrophy.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">M'bappé P, Grateau G. Osteo-articular manifestations of amyloidosis. Best Pract Res Clin Rheumatol 2012; 26:459.</a></li><li><a class="nounderline abstract_t">Spuler S, Emslie-Smith A, Engel AG. Amyloid myopathy: an underdiagnosed entity. Ann Neurol 1998; 43:719.</a></li><li><a class="nounderline abstract_t">Lawson TM, Bevan MA, Williams BD. Clinical images: Skeletal muscle pseudo-hypertrophy in myeloma-associated amyloidosis. Arthritis Rheum 2002; 46:2251.</a></li><li><a class="nounderline abstract_t">Windhagen A, Bufler J, Neudecker S. Gross muscle pseudohypertrophy in myeloma-associated light chain amyloidosis. Neurology 2005; 65:1670.</a></li><li><a class="nounderline abstract_t">Manoli I, Kwan JY, Wang Q, et al. Chronic myopathy due to immunoglobulin light chain amyloidosis. Mol Genet Metab 2013; 108:249.</a></li><li><a class="nounderline abstract_t">Tasca G, Modoni A, Nicoletti T, et al. Muscle hypertrophy in amyloid myopathy. Neuromuscul Disord 2019; 29:150.</a></li><li><a class="nounderline abstract_t">Dhir V, Shukla S, Haroon N, et al. Medical image. Arthritis and macroglossia. Multiple myeloma complicated by amyloidosis causing arthropathy. N Z Med J 2007; 120:U2534.</a></li><li><a class="nounderline abstract_t">Tsourdi E, Därr R, Wieczorek K, et al. Macroglossia as the only presenting feature of amyloidosis due to MGUS. Eur J Haematol 2014; 92:88.</a></li><li><a class="nounderline abstract_t">Gertz MA, Kyle RA. Myopathy in primary systemic amyloidosis. J Neurol Neurosurg Psychiatry 1996; 60:655.</a></li><li><a class="nounderline abstract_t">Rubin DI, Hermann RC. Electrophysiologic findings in amyloid myopathy. Muscle Nerve 1999; 22:355.</a></li><li><a class="nounderline abstract_t">Karacostas D, Soumpourou M, Mavromatis I, et al. Isolated myopathy as the initial manifestation of primary systemic amyloidosis. J Neurol 2005; 252:853.</a></li><li><a class="nounderline abstract_t">Hull KM, Griffith L, Kuncl RW, Wigley FM. A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features. Arthritis Rheum 2001; 44:1954.</a></li><li><a class="nounderline abstract_t">Mekinian A, Jaccard A, Soussan M, et al. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid 2012; 19:94.</a></li><li><a class="nounderline abstract_t">Ostrow LW, Corse AM, Morrison BM, et al. Expanding the spectrum of monoclonal light chain deposition disease in muscle. Muscle Nerve 2012; 45:755.</a></li><li><a class="nounderline abstract_t">Ghosh PS, Thaera GM, Tracy JA. Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy. Neurology 2013; 81:e184.</a></li><li><a class="nounderline abstract_t">Mandl LA, Folkerth RD, Pick MA, et al. Amyloid myopathy masquerading as polymyositis. J Rheumatol 2000; 27:949.</a></li><li><a class="nounderline abstract_t">Muchtar E, Derudas D, Mauermann M, et al. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome. Mayo Clin Proc 2016; 91:1354.</a></li><li><a class="nounderline abstract_t">Gisserot O, Landais C, Cremades S, et al. Amyloid arthropathy and Waldenström macroglobulinemia. Joint Bone Spine 2006; 73:456.</a></li><li><a class="nounderline abstract_t">Vitali C, Baglioni P, Vivaldi I, et al. Erosive arthritis in monoclonal gammopathy of uncertain significance: report of four cases. Arthritis Rheum 1991; 34:1600.</a></li><li><a class="nounderline abstract_t">Fautrel B, Fermand JP, Sibilia J, et al. Amyloid arthropathy in the course of multiple myeloma. J Rheumatol 2002; 29:1473.</a></li><li><a class="nounderline abstract_t">Katoh N, Tazawa K, Ishii W, et al. Systemic AL amyloidosis mimicking rheumatoid arthritis. Intern Med 2008; 47:1133.</a></li><li><a class="nounderline abstract_t">Fujishima M, Komatsuda A, Imai H, et al. Amyloid arthropathy resembling seronegative rheumatoid arthritis in a patient with IgD-kappa multiple myeloma. Intern Med 2003; 42:121.</a></li><li><a class="nounderline abstract_t">Wiernik PH. Amyloid joint disease. Medicine (Baltimore) 1972; 51:465.</a></li><li><a class="nounderline abstract_t">Yamada S, Takahashi W, Maruyama H, et al. [Multiple myeloma diagnosed due to development of amyloid arthritis]. Rinsho Ketsueki 2019; 60:791.</a></li><li><a class="nounderline abstract_t">Felea I, Fodor D, Schiotis R, et al. Ultrasound findings in AL musculoskeletal amyloidosis. Med Ultrason 2011; 13:76.</a></li><li><a class="nounderline abstract_t">Ehman EC, El-Sady MS, Kijewski MF, et al. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med 2019; 60:1234.</a></li><li><a class="nounderline abstract_t">Prokaeva T, Spencer B, Kaut M, et al. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum 2007; 56:3858.</a></li><li><a class="nounderline abstract_t">Elsaman AM, Radwan AR, Akmatov MK, et al. Amyloid arthropathy associated with multiple myeloma: a systematic analysis of 101 reported cases. Semin Arthritis Rheum 2013; 43:405.</a></li><li><a class="nounderline abstract_t">Pessler F, Ogdie AR, Mayer CT, et al. Amyloid arthropathy associated with multiple myeloma: polyarthritis without synovial infiltration of CD20+ or CD38+ cells. Amyloid 2014; 21:28.</a></li><li><a class="nounderline abstract_t">Edelson JG. Amyloid shoulder pads. Two cases of multiple myeloma. Acta Orthop Scand 1995; 66:292.</a></li><li><a class="nounderline abstract_t">Pras M, Itzchaki M, Prelli F, et al. Amyloid arthropathy: characterization of the amyloid protein. Clin Exp Rheumatol 1985; 3:327.</a></li><li><a class="nounderline abstract_t">Liepnieks JJ, Burt C, Benson MD. Shoulder-pad sign of amyloidosis: structure of an Ig kappa III protein. Scand J Immunol 2001; 54:404.</a></li><li><a class="nounderline abstract_t">Gordon DA, Pruzanski W, Ogryzlo MA. Synovial fluid examination for the diagnosis of amyloidosis. Ann Rheum Dis 1973; 32:428.</a></li><li><a class="nounderline abstract_t">Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32:45.</a></li><li><a class="nounderline abstract_t">Scott RB, Elmore SM, Brackett NC Jr, et al. Neuropathic joint disease (Charcot joints) in Waldenström's macroglobulinemia with amyloidosis. Am J Med 1973; 54:535.</a></li><li><a class="nounderline abstract_t">Subbarao K, Jacobson HG. Amyloidosis and plasma cell dyscrasias of the musculoskeletal system. Semin Roentgenol 1986; 21:139.</a></li><li><a class="nounderline abstract_t">Pambuccian SE, Horyd ID, Cawte T, Huvos AG. Amyloidoma of bone, a plasma cell/plasmacytoid neoplasm. Report of three cases and review of the literature. Am J Surg Pathol 1997; 21:179.</a></li><li><a class="nounderline abstract_t">Kirkel DM, Paal E, Ascensao J, Schechter GP. Multiple bony amyloidomas as an initial presentation of myeloma. Clin Lymphoma Myeloma 2009; 9:E18.</a></li><li><a class="nounderline abstract_t">Rotter J, Dowlati E, Jha RT, et al. Primary cervical spine AL-κ amyloidoma: A case report and review of the literature. Neuropathology 2019; 39:231.</a></li><li><a class="nounderline abstract_t">Salvarani C, Gabriel SE, Gertz MA, et al. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 1994; 37:1621.</a></li><li><a class="nounderline abstract_t">Audemard A, Boutemy J, Galateau-Salle F, et al. AL amyloidosis with temporal artery involvement simulates giant-cell arteritis. Joint Bone Spine 2012; 79:195.</a></li><li><a class="nounderline abstract_t">Churchill CH, Abril A, Krishna M, et al. Jaw claudication in primary amyloidosis: unusual presentation of a rare disease. J Rheumatol 2003; 30:2283.</a></li><li><a class="nounderline abstract_t">Ghinai RA, Mahmood S, Mukonoweshuro P, et al. Diagnosing Light Chain Amyloidosis on Temporal Artery Biopsies for Suspected Giant Cell Arteritis. J Neuroophthalmol 2017; 37:34.</a></li><li><a class="nounderline abstract_t">Estrada A, Stenzel TT, Burchette JL, Allen NB. Multiple myeloma-associated amyloidosis and giant cell arteritis. Arthritis Rheum 1998; 41:1312.</a></li><li><a class="nounderline abstract_t">Schima W, Amann G, Steiner E, et al. Case report: sicca syndrome due to primary amyloidosis. Br J Radiol 1994; 67:1023.</a></li><li><a class="nounderline abstract_t">Jardinet D, Westhovens R, Peeters J. Sicca syndrome as an initial symptom of amyloidosis. Clin Rheumatol 1998; 17:546.</a></li><li><a class="nounderline abstract_t">Hachulla E, Janin A, Flipo RM, et al. Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum 1993; 36:691.</a></li><li><a class="nounderline abstract_t">Foli A, Palladini G, Caporali R, et al. The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients. Amyloid 2011; 18 Suppl 1:80.</a></li><li><a class="nounderline abstract_t">Inazumi T, Hakuno M, Yamada H, et al. Characterization of the amyloid fibril from primary localized cutaneous nodular amyloidosis associated with Sjögren's syndrome. Dermatology 1994; 189:125.</a></li><li><a class="nounderline abstract_t">Meijer JM, Schonland SO, Palladini G, et al. Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum 2008; 58:1992.</a></li><li><a class="nounderline abstract_t">Perlat A, Decaux O, Gervais R, et al. Systemic light chain amyloidosis and Sjogren syndrome: an uncommon association. Amyloid 2009; 16:181.</a></li><li><a class="nounderline abstract_t">Wey SJ, Chen YM, Lai PJ, Chen DY. Primary sjögren syndrome manifested as localized cutaneous nodular amyloidosis. J Clin Rheumatol 2011; 17:368.</a></li><li><a class="nounderline abstract_t">Reyes CM, Rudinskaya A, Kloss R, et al. Scleroderma-like illness as a presenting feature of multiple myeloma and amyloidosis. J Clin Rheumatol 2008; 14:161.</a></li><li><a class="nounderline abstract_t">Sun L, Zhang L, Hu W, et al. Case report: One case of primary AL amyloidosis repeatedly misdiagnosed as scleroderma. Medicine (Baltimore) 2017; 96:e8771.</a></li><li><a class="nounderline abstract_t">Ladefoged C, Merrild U, Jørgensen B. Amyloid deposits in surgically removed articular and periarticular tissue. Histopathology 1989; 15:289.</a></li><li><a class="nounderline abstract_t">Rumpelt HJ, Braun A, Spier R, et al. Localized amyloid in the menisci of the knee joint. Pathol Res Pract 1996; 192:547.</a></li><li><a class="nounderline abstract_t">Yanagisawa A, Ueda M, Sueyoshi T, et al. Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid. Amyloid 2016; 23:26.</a></li><li><a class="nounderline abstract_t">Cole AS, Cordiner-Lawrie S, Carr AJ, Athanasou NA. Localised deposition of amyloid in tears of the rotator cuff. J Bone Joint Surg Br 2001; 83:561.</a></li><li><a class="nounderline abstract_t">Goffin YA, Thoua Y, Potvliege PR. Microdeposition of amyloid in the joints. Ann Rheum Dis 1981; 40:27.</a></li><li><a class="nounderline abstract_t">Mohr W, Kuhn C, Linke RP, Wessinghage D. Deposition of amyloid of unknown origin in articular cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60:259.</a></li><li><a class="nounderline abstract_t">Wullbrand A, Saeger W, Missmahl HP, et al. Amyloid in intervertebral discs of surgery and autopsy material. A new class of amyloid? Virchows Arch A Pathol Anat Histopathol 1990; 416:335.</a></li><li><a class="nounderline abstract_t">Goffin YA, McCrickard EL, Ameryckx JP, et al. Amyloidosis of the joints: evidence that human hip capsules have a unique predisposition for amyloid of the senile systemic type. Appl Pathol 1985; 3:88.</a></li><li><a class="nounderline abstract_t">Egan MS, Goldenberg DL, Cohen AS, Segal D. The association of amyloid deposits and osteoarthritis. Arthritis Rheum 1982; 25:204.</a></li><li><a class="nounderline abstract_t">Shimizu K, Higuchi K, Matsushita M, et al. Immunohistochemical studies of age-associated amyloid deposition in the joint of senescence-accelerated mouse (SAM). Z Rheumatol 1992; 51:243.</a></li><li><a class="nounderline abstract_t">Solomon A, Murphy CL, Kestler D, et al. Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I. Arthritis Rheum 2006; 54:3545.</a></li><li><a class="nounderline abstract_t">Niggemeyer O, Steinhagen J, Deuretzbacher G, et al. Amyloid deposition in osteoarthritis of the hip. Arch Orthop Trauma Surg 2011; 131:637.</a></li><li><a class="nounderline abstract_t">Takanashi T, Matsuda M, Yazaki M, et al. Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients. Amyloid 2013; 20:151.</a></li><li><a class="nounderline abstract_t">Akasaki Y, Reixach N, Matsuzaki T, et al. Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis. Arthritis Rheumatol 2015; 67:2097.</a></li><li><a class="nounderline abstract_t">Matsuzaki T, Akasaki Y, Olmer M, et al. Transthyretin deposition promotes progression of osteoarthritis. Aging Cell 2017; 16:1313.</a></li><li><a class="nounderline abstract_t">Clement CC, Moncrieffe H, Lele A, et al. Autoimmune response to transthyretin in juvenile idiopathic arthritis. JCI Insight 2016; 1.</a></li><li><a class="nounderline abstract_t">Eyanson S, Benson MD. Erosive arthritis in hereditary amyloidosis. Arthritis Rheum 1983; 26:1145.</a></li><li><a class="nounderline abstract_t">Shiraishi M, Ando Y, Mizuta H, et al. Charcot knee arthropathy with articular amyloid deposition in familial amyloidotic polyneuropathy. Scand J Rheumatol 1997; 26:61.</a></li><li><a class="nounderline abstract_t">Wilmes D, Wautier D, Jonckheere S, et al. Neuroarthropathy secondary to transthyretin amyloidosis (ATTR V30M). Acta Clin Belg 2012; 67:372.</a></li><li><a class="nounderline abstract_t">Yamashita T, Ando Y, Katsuragi S, et al. Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys. Muscle Nerve 2005; 31:41.</a></li><li><a class="nounderline abstract_t">Carr AS, Pelayo-Negro AL, Jaunmuktane Z, et al. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy. Neuromuscul Disord 2015; 25:511.</a></li><li class="breakAll">Wang AK, Gorevic PD. Neurologic Improvement after cervical decompression in wild type transthyretin amyloidosis. In: Companion to Peripheral Neuropathy: Illustrated Cases and New Developments, Dyck PJ, Dyck PJB, Engelstad HT, et al (Eds), Saunders, Philadelphia 2010. p.145.</li><li><a class="nounderline abstract_t">Pinto MV, Milone M, Mauermann ML, et al. Transthyretin amyloidosis: Putting myopathy on the map. Muscle Nerve 2020; 61:95.</a></li><li><a class="nounderline abstract_t">Kyle RA, Gertz MA, Linke RP. Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type. Am J Clin Pathol 1992; 97:250.</a></li><li><a class="nounderline abstract_t">Samões R, Taipa R, Valdrez K, et al. Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome. Amyloid 2017; 24:73.</a></li><li><a class="nounderline abstract_t">Russo M, Mazzeo A, Stancanelli C, et al. Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. J Peripher Nerv Syst 2012; 17:385.</a></li><li><a class="nounderline abstract_t">Nakase T, Yamashita T, Matsuo Y, et al. Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S). Intern Med 2019; 58:2695.</a></li><li><a class="nounderline abstract_t">Jercan A, Ene A, Jurcut R, et al. Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population. Orphanet J Rare Dis 2020; 15:34.</a></li><li><a class="nounderline abstract_t">Nakagawa M, Sekijima Y, Yazaki M, et al. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid 2016; 23:58.</a></li><li><a class="nounderline abstract_t">Youngstein T, Gilbertson JA, Hutt DF, et al. Carpal Tunnel Biopsy Identifying Transthyretin Amyloidosis. Arthritis Rheumatol 2017; 69:2051.</a></li><li><a class="nounderline abstract_t">Klein CJ, Vrana JA, Theis JD, et al. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol 2011; 68:195.</a></li><li><a class="nounderline abstract_t">Carr AS, Shah S, Choi D, et al. Spinal Stenosis in Familial Transthyretin Amyloidosis. J Neuromuscul Dis 2019; 6:267.</a></li><li><a class="nounderline abstract_t">Aus dem Siepen F, Hein S, Prestel S, et al. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Clin Res Cardiol 2019; 108:1324.</a></li><li><a class="nounderline abstract_t">Rubin J, Alvarez J, Teruya S, et al. Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier? Amyloid 2017; 24:226.</a></li><li><a class="nounderline abstract_t">Weihl CC, Mammen AL. Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy. Neuropathol Appl Neurobiol 2017; 43:82.</a></li><li><a class="nounderline abstract_t">Liewluck T, Milone M. Characterization of isolated amyloid myopathy. Eur J Neurol 2017; 24:1437.</a></li><li><a class="nounderline abstract_t">Spuler S, Carl M, Zabojszcza J, et al. Dysferlin-deficient muscular dystrophy features amyloidosis. Ann Neurol 2008; 63:323.</a></li><li><a class="nounderline abstract_t">Swaika A, Boczek NJ, Sood N, et al. Whole Exome Sequencing Leading to the Diagnosis of Dysferlinopathy with a Novel Missense Mutation (c.959G&gt;C). Case Rep Genet 2016; 2016:9280812.</a></li><li><a class="nounderline abstract_t">Liewluck T, Winder TL, Dimberg EL, et al. ANO5-muscular dystrophy: clinical, pathological and molecular findings. Eur J Neurol 2013; 20:1383.</a></li><li><a class="nounderline abstract_t">Lahoria R, Winder TL, Lui J, et al. Novel ANO5 homozygous microdeletion causing myalgia and unprovoked rhabdomyolysis in an Arabic man. Muscle Nerve 2014; 50:610.</a></li></ol></div><div id="topicVersionRevision">Topic 5616 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23040361" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Osteo-articular manifestations of amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9629841" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Amyloid myopathy: an underdiagnosed entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12209535" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical images: Skeletal muscle pseudo-hypertrophy in myeloma-associated amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16301505" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Gross muscle pseudohypertrophy in myeloma-associated light chain amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23465863" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Chronic myopathy due to immunoglobulin light chain amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30704860" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Muscle hypertrophy in amyloid myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17515938" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Medical image. Arthritis and macroglossia. Multiple myeloma complicated by amyloidosis causing arthropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23799910" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Macroglossia as the only presenting feature of amyloidosis due to MGUS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8648333" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Myopathy in primary systemic amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086896" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Electrophysiologic findings in amyloid myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15742103" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Isolated myopathy as the initial manifestation of primary systemic amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11508448" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22587492" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22499107" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Expanding the spectrum of monoclonal light chain deposition disease in muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24323446" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10782821" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Amyloid myopathy masquerading as polymyositis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27712634" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16087379" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Amyloid arthropathy and Waldenström macroglobulinemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1747145" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Erosive arthritis in monoclonal gammopathy of uncertain significance: report of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12136908" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Amyloid arthropathy in the course of multiple myeloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18552473" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Systemic AL amyloidosis mimicking rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12583633" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Amyloid arthropathy resembling seronegative rheumatoid arthritis in a patient with IgD-kappa multiple myeloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4565934" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Amyloid joint disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31391368" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : [Multiple myeloma diagnosed due to development of amyloid arthritis].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21390347" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ultrasound findings in AL musculoskeletal amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30954943" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17968927" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23992800" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Amyloid arthropathy associated with multiple myeloma: a systematic analysis of 101 reported cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24286442" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Amyloid arthropathy associated with multiple myeloma: polyarthritis without synovial infiltration of CD20+ or CD38+ cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7604718" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Amyloid shoulder pads. Two cases of multiple myeloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4085164" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Amyloid arthropathy: characterization of the amyloid protein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11555407" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Shoulder-pad sign of amyloidosis: structure of an Ig kappa III protein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4751779" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Synovial fluid examination for the diagnosis of amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7878478" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Primary systemic amyloidosis: clinical and laboratory features in 474 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4633108" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Neuropathic joint disease (Charcot joints) in Waldenström's macroglobulinemia with amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3085222" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Amyloidosis and plasma cell dyscrasias of the musculoskeletal system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9042284" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Amyloidoma of bone, a plasma cell/plasmacytoid neoplasm. Report of three cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19858048" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Multiple bony amyloidomas as an initial presentation of myeloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31044465" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Primary cervical spine AL-κamyloidoma: A case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7980674" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22209315" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : AL amyloidosis with temporal artery involvement simulates giant-cell arteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14528530" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Jaw claudication in primary amyloidosis: unusual presentation of a rare disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27556960" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Diagnosing Light Chain Amyloidosis on Temporal Artery Biopsies for Suspected Giant Cell Arteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9663490" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Multiple myeloma-associated amyloidosis and giant cell arteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8000827" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Case report: sicca syndrome due to primary amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9890691" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Sicca syndrome as an initial symptom of amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7683882" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21838441" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8075437" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Characterization of the amyloid fibril from primary localized cutaneous nodular amyloidosis associated with Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18576343" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19636991" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Systemic light chain amyloidosis and Sjogren syndrome: an uncommon association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21946462" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Primary sjögren syndrome manifested as localized cutaneous nodular amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18525436" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Scleroderma-like illness as a presenting feature of multiple myeloma and amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29390268" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Case report: One case of primary AL amyloidosis repeatedly misdiagnosed as scleroderma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2807186" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Amyloid deposits in surgically removed articular and periarticular tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8857641" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Localized amyloid in the menisci of the knee joint.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26701417" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11380132" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Localised deposition of amyloid in tears of the rotator cuff.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7469523" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Microdeposition of amyloid in the joints.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1681615" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Deposition of amyloid of unknown origin in articular cartilage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2106750" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Amyloid in intervertebral discs of surgery and autopsy material. A new class of amyloid?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3915948" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Amyloidosis of the joints: evidence that human hip capsules have a unique predisposition for amyloid of the senile systemic type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7066050" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The association of amyloid deposits and osteoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1476009" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Immunohistochemical studies of age-associated amyloid deposition in the joint of senescence-accelerated mouse (SAM).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17075859" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20848114" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Amyloid deposition in osteoarthritis of the hip.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23734638" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25940564" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28941045" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Transthyretin deposition promotes progression of osteoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26973882" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Autoimmune response to transthyretin in juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6615565" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Erosive arthritis in hereditary amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9057805" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Charcot knee arthropathy with articular amyloid deposition in familial amyloidotic polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23189548" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Neuroarthropathy secondary to transthyretin amyloidosis (ATTR V30M).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15536615" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25819286" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25819286" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31587306" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Transthyretin amyloidosis: Putting myopathy on the map.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1372147" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28413892" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23279339" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31178489" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32000831" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26852880" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28556554" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Carpal Tunnel Biopsy Identifying Transthyretin Amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20937937" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30856118" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Spinal Stenosis in Familial Transthyretin Amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30953182" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28906148" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28111778" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28888072" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Characterization of isolated amyloid myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18306167" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Dysferlin-deficient muscular dystrophy features amyloidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27195159" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Whole Exome Sequencing Leading to the Diagnosis of Dysferlinopathy with a Novel Missense Mutation (c.959G&gt;C).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23663589" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : ANO5-muscular dystrophy: clinical, pathological and molecular findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24889862" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Novel ANO5 homozygous microdeletion causing myalgia and unprovoked rhabdomyolysis in an Arabic man.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
